Proactive Investors
19 Oct 2026, 01:53 UTC · 1h ago
Lumos Diagnostics to provide US FebriDx update at quarterly results briefing
Impact · against what's priced in
The news is primarily a scheduling update for Lumos Diagnostics and a production update for HeLIX Exploration. While the upcoming data for FebriDx is a critical value driver for LDX, the mere announcement of a briefing date does not change current valuations; HeLIX's restart of helium production provides a concrete catalyst for output growth.
- HEX+0.50
No priced-in read yet
- In context
The CEO confirmed the restart of helium production at the Rudyard project, including the resumption of tube trailer filling and plans for expansion via further drilling.
Read from the article alone
